Alcohol and Atrial Fibrillation: More Reasons for Moderate Consumption

Reducing alcohol consumption should be included in the “package” of secondary prevention recommendations, not only for its impact on arteries, but also because it reduces atrial fibrillation (AF).

Consumo de alcohol y fibrilación auricular

Alcohol abstinence might improve arrhythmia symptoms and reduce the chances of recurrence in patients who have already had an episode of AF.

Regular alcohol consumers who were randomized to alcohol abstinence for 6 months experienced less than half of the hospitalizations due to atrial fibrillation compared with patients who continued their usual alcohol consumption.

Alcohol can function as a trigger for AF and it has been studied specifically in works that associated regular alcohol consumption with left atrial enlargement, impaired left atrial contraction, and adverse electrical remodeling.


Read also: Is Alcohol Good, Bad, or Neutral for Cardiovascular Health?


Whether abstinence from alcohol could reduce arrhythmia in patients with a history of AF was still unclear. This is precisely the contribution made by this work, recently published in the prestigious New England Journal of Medicine.

This Alcohol-FA study randomized 140 patients to alcohol abstinence or consumption in the amount they already consumed regularly. The group randomized to abstinence accomplished an 87.2% reduction in their total alcohol intake (from 17 drinks per week to just 2 drinks). The group with continued consumption also slightly reduced the amount (about 20%, from 16 to 13 drinks per week).

Atrial fibrillation recurrence (one of the primary endpoints) was significantly lower in the abstinence group vs. the control group (53% vs. 73%). Additionally, the period before recurrence was longer.


Read also: Progress of patients with hypertrophic cardiomyopathy treated with alcohol septal ablation.


On top of the benefits in terms of arrhythmia, alcohol abstinence was associated with obesity reduction and less symptoms due to arrhythmia.

There are even data suggesting that a 6-month abstinence could reduce both systolic and diastolic pressure.

On the other hand, alcohol does not seem to be the true culprit behind arrhythmia. Abstinence may reduce recurrence and symptoms for a while, but it is not a definitive solution.


Read also: FFR in the Time of ISCHEMIA.


There is also another undeniable truth: complete abstinence is very hard to achieve. This study was originally planned with a 12-month follow-up, but that had to be reduced to only 6 months because patients refused to enroll if they had to spend a year without drinking. About 70% of patients who were invited to take part in this study refused randomization after considering that they would not be able to maintain their abstinence.

All of this applies to regular alcohol consumption: there is no evidence suggesting that occasional consumption may prevent cardiovascular events such as an episode of atrial fibrillation.

Original Title: Alcohol abstinence in drinkers with atrial fibrillation.

Reference: Voskoboinik A et al. N Engl J Med. 2020;382:20-28.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA 2024 | VANISH2 Trial

Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

STEACS and the Use of Bivalirudin vs. Heparin: In Search of BRIGHT-4 Outcomes

Various studies and registries have previously shown the impact of post-percutaneous coronary intervention (PCI) complications on the survival of patients with ST-segment elevation acute...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...